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BY  T  LYMPHOCYTES 
II.  T-Cell Activation by Direct Modification of Macrophage 
Histocompatibility Antigens 
BY  DAVID W.  THOMAS* AND ETHAN M.  SHEVACH 
(From the Laboratory of Immunology, National Institute of Allergy and Infectious  Diseases, 
National Institutes of Health, Bethesda,  Maryland 20014) 
In a previous study we reported a technique for the in vitro generation of a 
primary proliferative response by guinea pig T cells to soluble protein antigens 
involving two consecutive cultures (1). By this procedure we found that T cells 
from (2  x  13)F1 guinea pigs primed with antigen-pulsed macrophages derived 
from one parental strain could be restimulated only with the antigen-pulsed 
macrophages derived from the parental strain used for initial sensitization, but 
not  with  macrophages derived from  the  other  parental  strain.  This  result 
suggests that the primary genetic restriction of the F1 T-cell response may be 
imposed by the type of macrophage used for initial sensitization, irrespective of 
the/-region-associated (Ia) 1 antigen which that macrophage expressed. In this 
respect, these observations would support the concept that T cells do not recog- 
nize antigens per se, but can only be sensitized to antigen-modified membrane 
components or to complexes of antigen combined with certain membrane mole- 
cules. However, since F1 T cells and parental macrophages share Ia antigens, 
the  possibility  that  Ia  homology is  required for efficient T-cell-macrophage 
interactions cannot be ruled out. A direct test to differentiate between these two 
possibilities is to determine ifT cells can be specifically sensitized with antigens 
presented by  allogeneic macrophages.  In  our  previous  study,  this  was  not 
possible,  though, since T cells sensitized with antigen-pulsed allogeneic macro- 
phages produced a substantial secondary mixed leukocyte reaction (MLR) that 
obscured any antigen-specific reaction that might have been present. Therefore, 
it was necessary to find some means of eliminating the MLR in order to detect 
specific T-cell priming to antigen presented on allogeneic cells. 
Since  it  has  previously been  shown that  the  MLR  induced by allogeneic 
macrophages can be inhibited by alloantisera directed against macrophage Ia 
antigens (2), we attempted to use anti-Ia sera to eliminate the MLR in the in 
vitro T-cell priming with antigen-pulsed allogeneic macrophages. However, in 
the course of these experiments we made the fortuitous observation that macro- 
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phages bearing anti-!a antibodies stimulated T-cell proliferation.  Under these 
conditions T cells could be specifically stimulated by anti-Ia-treated syngeneic or 
allogeneic macrophages. In addition, we found that antiserum against the B.1 
antigen of the guinea pig major histocompatibility complex (MHC), the homo- 
logue of the mouse H-2K or H-2D antigens expressed by both strain 2 and strain 
13 guinea pigs, also elicited T-cell proliferation and that the anti-B.l-induced 
stimulation appeared to be regulated by/-region gene products. These results 
are discussed with respect to the role of/-region gene products in the immuno- 
genic complex recognized by T cells. 
Materials and Methods 
Animals.  Inbred  strain  2,  strain  13,  and  (2  x  13)F1 guinea pigs were obtained  from the 
Division of Research Services, National Institutes of Health, Bethesda, Md. 
Preparation of Cells.  Guinea pigs were injected intraperitoneally with 25 ml of sterile mineral 
oil (Marcol 52; Humble Oil & Refining Co., Houston, Texas) and the resulting peritoneal exudate 
was harvested 3-4 days later. This cell population consisting of approximately 75% macrophages, 
10% neutrophils, and 15% lymphocytes was used as a source of macrophages for in vitro priming. 
The unfractionated peritoneal exudate cells (5-10  x  106 ml) were incubated for 1 h  at 37°C in 
Hanks' balanced salt solution containing 25  ~g/ml of mitomycin C  (Sigma Chemical Co.,  St. 
Louis,  Mo.) and washed four times to remove the unbound mitomycin. A T-lymphocyte-enriched 
cell  population was prepared  by passing lymph node cells  from animals injected  in  the foot  pads 
several weeks previously with complete Freund's adjuvant (CFA; Difco  Laboratories,  Detroit, 
Mich.) over a rayon wool adherence  column (3). 
Preparation of  Alloantisera.  A strain  13 anti-strain  2 (anti-la.2,4)  serum and a strain  2 anti- 
strain  13 (anti-la.l,3)  serum were prepared  as  previously  described  (4).  In  brief,  the animals  were 
cross-immunized with cell  suspensions of  lymph node and spleen cells  emulsified in CFA. The 
animals were boosted 2 and 4 wk later by the intradermal  or intraperitoneal  injections  of 
suspensions of  lymph node and spleen cells  in saline.  6-8 wk ai~r primary immunization the 
animals were exsanguinated; the sera were heat inactivated  at  56°C for  45 rain  and sterilized  by 
Millipere  filtration.  Antisera to  the  B.  1  alloantigen  were  raised  in  a  similar  manner  by  immuniza- 
tion  of  outbred B.2,  la.1,3  animals with inbred strain  13 (B.1,  Ia.1,3)  cells.  All of  the cytotoxic 
activity  could  be  removed from  this  antiserum  by absorption  with  either  inbred strain  2 or  strain 
13  cells.  All  antisera  were  specific  by  physicochemical criteria  for  Ia  antigens  or  the  B.1  antigen as 
determined  by immunoprecipitation  of  a tritiated  cell  extract  and analysis  by polyacrylamide gel 
electrophoresis  (kindly  performed by Dr. B. D. Schwartz). 
In Vitro  Priming.  T-cell-enriched  lymph node cells  (5 x 10  e) were primed by culturing  with 
untreated macrophages (1 × 10  e) in 17 x 100 mm  tissue  culture  tubes in a total  vol of  1.5 ml of 
EHAA  medium (5),  containing L-glutamine (300  ~g/ml),  penicillin  (100  U/ml), streptomycin (100 
pg/ml), 5-fluorocytosine  (5 ~g/ml), 2-mercaptoethanol  (5 x  10  -5 M), and 5% heat-inactivated 
normal guinea  pig  serum (NGPS) or  alloantiserum.  In  some experiments, as  indicated  in  the  table 
legends,  the macrophages (2-5 x 10  ~)  were incubated in  20-50 pl  of  antiserum  for  30 rain  at  37°C; 
the antiserum-treated  macrophages were  then  washed twice  to  remove  the  unbound antiserum  and 
mixed  with  T lymphocytes. During  the  primary  culture  the  cells  were  incubated for  i  wk at  37°C in 
2% CO2 in  air.  On the  3rd day of  the  first  culture  the medium was  decanted  and replaced  with 1.5 
ml of  fresh  EHAA  medium containing 5% NGPS or alloantiserum. 
In Vitro  Assay of  DNA  Synthesis.  After  the 7-day initial  culture  approximately  20-30% of  the 
original  cell  number was  recovered and  the cells  were approximately  95% viable  as  determined  by 
trypan  blue  exclusion.  The  antigen-primed  T cells  (1-2  x 105  cells  per  well)  recovered  from  the  first 
culture  were restimulated in  the second  culture  in microtiter  plates  (Cooke Laboratory  Products 
Div.,  Dynatech Laboratories  Inc.,  Arlington,  Va.) with  fresh  peritoneal  exudate  cells  (1 x 105  per 
well)  in a total  vol of  0.2 ml of  EHAA  medium containing 5% NPGS  or alloantiserum. In some 
experiments  the stimulator cells  were treated  with antiserum before  culture  as  described  above. 
After  incubation  for  2  days  at  37°C in  5% COs in  air,  1 ~Ci  of  tritiated  thymidine (3H-TdR, specific 
activity  6.7  Ci/mmol; New England Nuclear, Boston, Mass.)  was added  to  each  well.  The amount 
of  radioactivity  incorporated  into  cellular  DNA  was determined after  an additional  18-h  incuba- DAVID  W.  THOMAS  AND  ETHAN  M.  SHEVACH  909 
tion with the aid ofa semiautomated microharvesting device (6). The results of triplicate cultures 
are expressed as either total counts per minute per culture  (cpm) or as the difference between 
antigen-stimulated and nonstimulated control cultures (A cpm). 
Results 
T-Lymphocyte  Activation  by Anti-Ia Antiserum.  When  strain  13  T  cells 
were incubated with syngeneic macrophages in the presence of 2 anti-13 alloan- 
tiserum in the first culture and transferred to fresh strain 13 macrophages in the 
presence of 2 anti-13 antiserum  in the second culture substantial T-cell activa- 
tion occurred, as measured by increased DNA synthesis (Table I, line 4). This 
stimulation appeared to be specific for 2 anti-13-induced T-cell priming since no 
activation occurred when 2 anti-13 sera was included in only the first (Table I, 
line  3)  or  second  (Table  I,  line  2)  cultures.  Similarly,  no  stimulation  was 
observed when NGPS was included in both cultures (Table I, line 1). Since the 2 
anti-13 antiserum is directed only against the strain 13 Ia antigens, this stimu- 
lation results either from direct antibody modification of Ia or from priming to 
anti-Ia  idiotypic determinants.  The former was suggested by the failure of 13 
anti-2 alloantiserum in the first and second cultures to activate strain 13 T cells 
indicating that activation results from anti-Ia binding to the T cells or macro- 
phages and not nonspecific absorption of alloantibodies (Table I, lines 6 and 7). 
The failure of 2 anti-13 antiserum to activate T cells in the presence of strain 2 
macrophages in the second culture (Table I, line 5) indicates that this antibody- 
induced  stimulation  results  from antibody binding  to the  macrophage  rather 
than by direct action on the T cell. This was substantiated by the fact that 2 anti- 
13-pulsed macrophages were efficient stimulators and by experiments in which 
T  cells were specifically activated by alloantisera  directed only against alloge- 
neic macrophages  (see below). 
T-Lymphocyte Activation  by Anti-Ia-Treated  Allogeneic Macrophages.  Pre- 
vious studies have shown that the response of guinea pig T lymphocytes stimu- 
lated  with  allogeneic  macrophages  in  a  MLR could be dramatically  reduced 
by anti-Ia  serum  directed  against  the  macrophage  (2).  By this  technique  we 
were able to demonstrate that T cells could be specifically activated by anti-Ia 
bound  to  allogeneic  macrophages  (Table  II).  When  strain  13  T  cells  were 
stimulated  with allogeneic strain  2 macrophages in the presence of NGPS in 
the first and second cultures a substantial secondary MLR was observed (Table 
II, line 2). If 13 anti-2 antiserum was included in the first culture but replaced 
with NGPS in the second culture, the secondary MLR was reduced approximately 
80% (Table II, line 3). However, if 13 anti-2 antiserum was included in both the 
first and second cultures a substantial increase in T-cell proliferation was seen 
which  approximated  that  seen in  the  uninhibited  secondary MLR  (Table II, 
line 4). Similar results were obtained with strain 2 T cells stimulated with strain 
13 macrophages in the presence of 2 anti-13 antiserum  (Table II, bottom half). 
These results suggest that at the same time that the MLR is blocked by anti-Ia 
sera  directed  against  the  macrophage,  T  cells  are  also specifically sensitized 
to the anti-Ia antibodies bound to the allogeneic macrophage. 
T-Lymphocyte Activation by Anti-B.1  Antiserum.  Since antibodies directed 
solely against macrophage Ia antigens could activate T cells it became impor- 
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TABLE I 
Stimulation of Strain 13 T Lymphocytes by 2 Anti-13 AUoantiserum 
First culture*  Second cultures 
T lympho-  Macro-  Macro- 
Sera  Sera  '~H-TdR cpm 
cyte  phages  phages 
13  13  NGPS  13  NGPS  1,580 
13  13  NGPS  13  2 Anti-13  2,370 
13  13  2 Anti-13  13  NGPS  700 
13  13  2 Anti-13  13  2 Anti-13  231800 
13  13  2 Anti-13  2  2 Anti-13  3,390 
13  13  13 Anti-2  13  13 Anti-2  1,540 
13  13  13 Anti-2  2  13 Anti-2  1,160 
* Strain 13 T lymphocytes were incubated with strain 13 macrophages for 7 days in the presence of 
5% 2 anti-13 or 13 anti-2 serum as indicated. 
S The incorporation of 3H-TdR  was determined 4 days after transferring the cells recovered from 
the first cultures to fresh strain 13 or strain 2 macrophages in the presence of 5% 2 anti-13 or 13 
anti-2 serum in microtiter wells. 
caused  similar  stimulation.  We  found  that  strain  13  T  cells  cultured  with 
syngeneic macrophages in the presence of antiserum  directed against the B. 1 
antigen of the guinea pig MHC, the homologue of the mouse H-2K and/or H-2D 
antigens,  in both the first and second cultures were also activated  (Table III). 
This  activation  was  specific for  anti-B.1  since  T  cells primed  with  anti-B.1- 
treated macrophages in the first culture could not be restimulated by 2 anti-13- 
treated macrophages in the second culture. In similar fashion, strain  13 T cells 
primed with 2 anti-13-treated macrophages in the first culture were incapable of 
being restimulated by anti-B.l-treated  macrophages in the second culture but 
showed a  good secondary response with 2 anti-13-treated  macrophages.  How- 
ever, if the T cells were primed with macrophages simultaneously treated with 
both 2 anti-13 and anti-B.1 antisera in the first culture they could be restimu- 
lated with either 2 anti-13  or anti-B.l-treated  macrophages in the second cul- 
ture. 
Genetic  Restriction  on  the  T-Lymphocyte  Activation  by  Anti-B.1  Antise- 
rum.  Although T cells could be specifically activated by anti-B.l-treated mac- 
rophages we found that  this response was restricted to the histocompatibility 
type of the macrophage used for initial sensitization  (Table IV). If (2 x  13)F1 T 
cells were stimulated with anti-B.l-treated macrophages from one parent in the 
first culture they could only be restimulated  with the anti-B.l-treated  macro- 
phage used for the initial sensitization,  and not with those of the other parent 
despite the fact that both parents are B.1 positive. For example,  (2  x  13)F1 T 
cells primed  with  anti-B.l-treated  strain  13  macrophages  in the  first  culture 
could only be restimulated with anti-B.l-treated strain 13 or (2 x  13)F1, but not 
strain  2,  macrophages in the second culture.  In similar fashion,  (2  x  13)F~ T 
cells  primed  with  anti-B.l-treated  strain  2  macrophages  in  the  first  culture 
could only be restimulated with strain 2 or (2  x  13)F1, but not strain  13, anti- 
B.l-treated  macrophages.  F1  T  cells  initially  sensitized  with  anti-B.l-treated 
(2  x  13)F~ macrophages  could be restimulated  with  anti-B.l-treated  macro- 
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TABLE II 
Stimulation  of T Lymphocytes by Anti-Ia Sera Directed against Allogenic 
Macrophages 
First culture*  Second culture* 
T lym-  Macro-  Macro-  Sera  Sera  phocyte  phages  phages 
aH-TdR cpm 
Exp.  1  Exp.  2 
13  2  NGPS  13  NGPS  4,070  268 
13  2  NGPS  2  NGPS  142,700  181,180 
13  2  13 Anti-2  2  NGPS  32,030  45,780 
13  2  13 Anti-2  2  13 Anti-2  821000  188~000 
2  13  NGPS  2  NGPS  3,600  339 
2  13  NGPS  13  NGPS  ND§  10,560 
2  13  2 Anti-13  13  NGPS  30,700  1,547 
2  13  2 Anti-13  13  2 Anti-13  116r300  131310 
*,* Same as in the footnotes for Table I. 
§ ND, not determined. 
Discussion 
The MHC includes a number of genes which control or regulate the immune 
response.  Previous studies  have  shown  the/-region gene products  play  an 
important role for effective interaction between T cells and macrophages (7-10). 
Although the nature of this collaboration is at present unknown one possibility 
is that antigen may specifically bind to the macrophage Ia products and create 
an immunogenic complex recognized by T  cells as proposed by Shevach (10). 
This concept is supported by our finding that antibody bound solely to macro- 
phage  Ia  antigens is  capable  of sensitizing T  cells.  Although we could not 
determine the nature of this antibody-induced stimulation, two possibilities are 
suggested.  One possibility is that the binding of antibody to the Ia antigen 
induces a change in the Ia molecule which T cells recognize as an altered-self 
immunogen. Another possibility is that T cells react against idiotypic determi- 
nants of the anti-Ia antibody which are focused on the macrophage Ia antigens. 
In  addition to  our finding that  the  anti-Ia  antibodies  bound  to  syngenic 
macrophages was stimulatory we were also able to use this technique to specifi- 
cally activate T  cells with anti-Ia-treated allogeneic macrophages. This was 
made possible by the fact that anti-Ia antiserum directed against the allogeneic 
macrophage will block much of the MLR,  presumably by interfering with Ia 
recognition by T cells (2). Our results showed that at the same time that anti-Ia 
antiserum directed against the allogeneic macrophage blocks the MLR,  the T 
cells  also  become specifically sensitized  to  the  anti-Ia  antibodies  bound  to 
allogeneic macrophages. We interpret this finding as a demonstration that T 
cells can be specifically activated by antigens associated with allogeneic/-region 
gene products if they are initially sensitized with the allogeneic immunogen. 
These results support the concept that T-cell-macrophage interactions do not 
require shared MHC gene products, but that T cells recognize antigens associ- 
ated with the macrophage histocompatibility type with which they were ini- 
tially sensitized (1). Further evidence for this concept is our finding that strain 912  T-LYMPHOCYTE  RECOGNITION 
TABLE III 
Stimulation of Strain 13 T Lymphocytes by Anti-B.1 Serum 
Second culture,$ ~H-TdR cpm 
Sera 
2 Anti-13  Anti-B. 1 
First culture* 
Sera 
2 Anti-13  69,340  1,910 
Anti-B. 1  1,950  10,550 
2 Anti-13 and anti-B.1  110,310  39,230 
* Strain  13 T  lymphocytes were incubated for 7 days with strain 13 macro- 
phages pulsed with 2 anti-13 serum, anti-B.1 serum, or both, as described in 
the Materials and Methods. 
The incorporation of 3H-TdR was determined 3 days after transferring the 
cells recovered from the first culture to fresh 2  anti-13 or anti-B.l-pulsed 
strain 13 macrophages in microtiter wells as described in the Materials and 
Methods. 
13 T cells rendered unresponsive to strain 2 alloantigens by bromodeoxyuridine 
and light treatment can be specifically sensitized with hapten-modified strain 2 
macrophages} Several groups of investigators have reached similar conclusions 
for  the  genetic  requirements  of lymphocyte-macrophage  interactions  in  the 
mouse (11-13). In all of these studies it was found that mouse T cells recognize 
antigen  associated only with macrophages of the same histocompatibility type 
used for the initial sensitization. 
Another intriguing  observation is our finding that antisera directed against 
the B. 1 antigen of the guinea pig MHC, the homologue of the mouse H-2K and 
H-2D antigens,  also activated T  cells in a  manner  similar to that found with 
anti-Ia  antisera.  This  activation  was specific for the anti-B.l-sera  since there 
was no cross-reaction with the anti-Ia-induced activation and indicates that the 
anti-Ia and anti-B. 1 sera do not cause a  generalized nonspecific modification of 
the stimulator cells. 
Another related and surprising finding was that the T-cell activation to the 
anti-B.l-sera  was genetically  restricted  to  the  histocompatibility  type of the 
anti-B.l-treated  macrophage  used for the  initial  sensitization.  Since the  B.1 
antigens  expressed by the strain  2 and strain  13 guinea pigs are serologically 
identical it was anticipated that (2 x  13)F, T cells initially sensitized with anti- 
B.l-treated macrophages from one parent might have been restimulated  with 
anti-B.l-treated  macrophages from either parent.  Instead,  we found that  (2  × 
13)F,  T  cells  ser~sitized  with  anti-B.l-treated  parental  macrophages  could be 
restimulated only with anti-B. 1-treated macrophages of the parental type used 
for the initial sensitization,  but not with those of the other parent.  Due to the 
fact that the strain 2 and strain 13 MHC's differ only with respect to Ia antigens, 
these results suggest that the immunogenic complex recognized by the T cells 
may consist of the antisera-bound B. 1 in association with Ia antigens. It should 
be noted  that  although  the  strain  2  and  strain  13  antigens  are  serologically 
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TABLE  IV 
Genetic Restriction on the Response of(2  × 13)F1 T Lymphocytes to Anti-B.1-Treated 
Parental Macrophages 
First culture* 
T lymphocyte 
Second culture,* 3H-TdR A cpm 
Anti-B.l-pulsed macrophages 
Anti-B. 1-pulsed 
macrophages  (2 x 13)F~  2  13 
Exp. 1, (2 x 13)F~  (2 × 13)F~  17,530  3,950  42,710 
2  10,430  6,610  2,970 
13  20~790  0  38,800 
(2 × 13)F1  3~280  2~720  5~500 
13  5,650  830  8,620 
Exp. 2, (2 x 13)F, 
Exp. 3, (2 x 13)F,  2  ND§  19,680  1,360 
13  0  48,610 
* (2 × 13)F1 T lymphocytes  were incubated 7 days with anti-B.l-pulsed (2 x 13)F1, strain 2, or 
strain 13 macrophages as described in the Materials and Methods. 
$ The incorporation of 3H-TdR was determined 3 days after transferring the cells recovered  from 
the  first culture to fresh anti-B.l-pulsed (2  ×  13)F~, strain  2,  or strain  13 macrophages in 
microtiter wells as described in the Materials and Methods. 
§ ND, not determined. 
identical at the present time, it is possible that the B.1 antigens expressed by the 
strain 2 guinea pigs are structurally different from the B.1 antigens expressed 
by  strain  13  guinea  pigs.  In  addition,  while  the  strain  2  and  strain  13  B.1 
antigens are serologically identical, T cells may recognize differences which are 
not detected by antibody. Another possible explanation for these results may be 
that while strain 2 and strain 13 guinea pigs differ primarily by Ia antigens of 
the MHC, there are also other genetic differences between these strains. Thus, 
the  genetic restriction of the  F,  T-cell response to  anti-B.l-treated parental 
macrophages may actually reflect differences at genetic loci other than the I 
region.  To  test  this  possibility  experiments are  in  progress  using  anti-B.1- 
treated macrophages from outbred animals with different Ia antigens than the 
immunizing strain to determine if the response is regulated by Ia antigens or by 
other genetic loci unrelated to the/-region. 
There is ample evidence that the products of the MHC are capable of func- 
tional interaction with other cell surface molecules. Bevan (14) has shown that 
mouse cytotoxic T cells directed against minor alloantigens must share the same 
allele at either the H-2K or H-2D locus with the target cell. Similarly, several 
other investigators  (15-17)  have  dem-nstrated  an  association between MHC 
antigens and tumor-specific transplantation antigens.  Although the chemical 
basis for these molecular interactions is as yet unknown, it is not too surprising 
that a  similar process may be  mediated by/-region antigens on other MHC 
antigens. One might speculate that a direct physical linkage occurs between the 
Ia and modified B. 1 antigens or possibly that the antisera-modified B. 1 antigen 
renders  it  susceptible  to  further modification by  the /-region  gene  product, 
perhaps through some enzymatic mechanism. Two possibilities for the function 
of/-region gene products suggested by our studies are that Ia antigens may 914  T-LYMPHOCYTE  RECOGNITION 
serve to directly present antigens associated with the Ia molecule, and to in- 
directly aid in the presentation of antigens associated with other membrane 
components, such as the B.1 antigens. 
Our  observation  that  antibodies  bound  to  stimulator cells to  produce  an 
immunogenic complex that sensitizes T lymphocytes provides a novel approach 
for studying the nature of the antigenic complex recognized by T cells. It is thus 
possible to selectively modify membrane antigens and determine if the specific 
antibody is capable of sensitizing T cells and which type of membrane antigens 
are included in the antisera-induced immunogenic complex. In this manner we 
have shown that antibodies bound to both Ia or B. 1 antigens of the guinea pig 
MHC on the stimulator macrophage specifically sensitizes T cells.  One clinical 
implication of these  findings  may be  that  antibodies  produced against  self 
components including MHC antigens in some autoimmune disease states may 
elicit a response against the antibody-self complex and thereby perpetuate the 
autoimmune reaction (18). 
Summary 
In order to analyze the molecular structures involved in T-cell recognition we 
developed an in vitro primary response against alloantisera bound to histocom- 
patibility antigens in which nonimmune guinea pig T cells can be sensitized and 
subsequently challenged in tissue culture with antisera-treated macrophages. If 
macrophages were incubated with alloantisera directed against the/-region- 
associated  (Ia)  antigens of the  guinea pig major histocompatibility complex 
(MHC)  T  cells could be  sensitized to  the  antisera bound to  macrophage Ia 
determinants. Anti-la-treated syngeneic macrophages in the first and second 
cultures  elicited  specific  T-cell  activation,  as  measured by  increased  DNA 
synthesis, to the antisera-induced immunogenic determinants. Similarly, anti- 
Ia-treated allogeneic macrophages also specifically  stimulated T cells to antisera 
bound to allogeneic Ia determinants while reducing the mixed leukocyte reac- 
tion. Antisera to the B. 1 antigens of the guinea pig MHC, the homologue of the 
mouse H-2K or H-2D antigens, also elicited specific T-cell activation that did not 
cross-react with that produced by the anti-Ia alloantisera.  Furthermore, the 
anti-B. 1-induced stimulation appeared to be associated with the Ia antigens of 
the macrophage used for priming since (2  x  13)F1 T cells sensitized with anti- 
B. 1-treated parental macrophages could be restimulated only with the parental 
macrophage used for initial sensitization, and not with those of the other parent. 
Since the  parental  strain  2  and  strain  13  guinea pigs  express serologically 
identical B.1 antigens and differ only by Ia antigens of the MHC, this observa- 
tion suggests that both B. 1 and Ia antigens may be included in the immunogenic 
complex recognized by T cells.  However, we cannot rule out the possibility that 
this restriction is due to other genetic differences  between strain 2 and strain 13 
guinea pigs that is unrelated to the/-region. We interpret these findings as 
showing that macrophage Ia antigens may serve to directly present antigens 
bound to the Ia molecule, and possibly indirectly aid in the presentation of 
antigens bound to other membrane components, such as the B. 1 antigens. 
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